
Pyxis Oncology, Inc.
PYXSHealthcare|Biotechnology|US
$1.66
+0.05 (+3.11%)
DCF Value
$1.70
Tangible Book / Share
$0.49
Cash / Share
$0.67
Ownership Breakdown
58.8%
Float
63.4M
Shares Outstanding
37.3M
Float Shares
Major Holders (32)
Combined: 199.7%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Craig D. Gordon | HC, IN | 16.40% | 20,441,948 | Oct 9, 2026 | 13D/G |
| GordonMD Global Investments LP | IA, PN | 16.40% | 20,441,948 | Oct 9, 2026 | 13D/G |
| GordonMD Long Biased GP LLC | Other | 16.40% | 20,441,948 | Oct 9, 2026 | 13D/G |
| GordonMD Long Biased Master Fund LP | Partnership | 16.40% | 20,441,948 | Oct 9, 2026 | 13D/G |
| Lara Sullivan, M.D. | Individual | 11.21% | 7,543,007 | Apr 2, 2025 | 13D/G |
| Lara Sullivan | Individual | 10.30% | 6,624,699 | Dec 23, 2024 | 13D/G |
| BVF Partners L P/Il | IA, PN | 9.99% | 8,336,902 | Jul 10, 2026 | 13D/G |
| Lampert Mark N | Individual | 9.99% | 8,336,902 | Jul 10, 2026 | 13D/G |
| BVF Inc/Il | Corporation | 9.99% | 8,336,902 | Jul 10, 2026 | 13D/G |
| BVF GP Holdings LLC | Other | 9.20% | 7,695,734 | Jul 10, 2026 | 13D/G |
| Biotechnology Value Fund L P | Partnership | 5.50% | 4,611,887 | Jul 10, 2026 | 13D/G |
| BVF I GP LLC | Other | 5.50% | 4,611,887 | Jul 10, 2026 | 13D/G |
| Coastlands Capital GP LLC | Other | 5.42% | 6,448,907 | Oct 5, 2026 | 13D/G |
| Coastlands Capital LP | IA, PN | 5.42% | 6,448,907 | Oct 5, 2026 | 13D/G |
| Coastlands Capital Partners LP | Partnership | 5.42% | 6,448,907 | Oct 5, 2026 | 13D/G |
| Matthew D. Perry | HC, IN | 5.42% | 6,448,907 | Oct 5, 2026 | 13D/G |
| Coastlands Capital LLC | HC, OO | 5.42% | 6,448,907 | Oct 5, 2026 | 13D/G |
| Janaka Sheehan Maduraperuma | HC, IN | 5.16% | 4,300,888 | Nov 3, 2026 | 13D/G |
| Benjamin Alexander Smith | HC, IN | 5.16% | 4,300,888 | Nov 3, 2026 | 13D/G |
| Laurion Capital Management LP | IA, PN | 5.16% | 4,300,888 | Nov 3, 2026 | 13D/G |
| Integrated Core Strategies (US) LLC | Other | 4.00% | 2,484,992 | May 6, 2025 | 13D/G |
| BVF II GP LLC | Other | 3.70% | 3,083,847 | Jul 10, 2026 | 13D/G |
| Biotechnology Value Fund II LP | Partnership | 3.70% | 3,083,847 | Jul 10, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 1.50% | 926,805 | Jul 17, 2025 | 13D/G |
| Millennium Group Management LLC | Other | 1.30% | 818,134 | Oct 14, 2025 | 13D/G |
| Millennium Management LLC | Other | 1.30% | 818,134 | Oct 14, 2025 | 13D/G |
| Israel A. Englander | Individual | 1.30% | 818,134 | Oct 14, 2025 | 13D/G |
| BVF Partners OS Ltd. | Corporation | 0.60% | 518,280 | Jul 10, 2026 | 13D/G |
| Biotechnology Value Trading Fund OS LP | Partnership | 0.60% | 518,280 | Jul 10, 2026 | 13D/G |
| Ridgeback Capital Management LLC | Other | 0.60% | 359,231 | Feb 14, 2025 | 13D/G |
| Ridgeback Capital Investments LLC | Other | 0.60% | 359,231 | Feb 14, 2025 | 13D/G |
| Ridgeback Capital Investments L.P. | Other | 0.60% | 359,231 | Feb 14, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 24,488,568 acquired · 70,000 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| HUMPHREY RACHEL | director | Nov 6, 2026 | AWARD | 34,500 | $1.66 | $57.3K | Form 4 |
| GordonMD Global Investments LP | 10 percent owner | Oct 1, 2026 | BUY | 7,172,000 | $3.50 | $25.1M | Form 4 |
| GordonMD Global Investments LP | 10 percent owner | Oct 1, 2026 | BUY | 5,517,000 | — | — | Form 4 |
| GordonMD Global Investments LP | 10 percent owner | Oct 1, 2026 | BUY | 7,546,766 | $3.50 | $26.4M | Form 4 |
| Civik Thomas | director, officer: CEO & Chairman of the Board | Sep 4, 2026 | AWARD | 2,503,050 | $3.89 | $9.7M | Form 4 |
| Dupont Jakob | director | Aug 20, 2026 | AWARD | 46,000 | $3.12 | $143.5K | Form 4 |
| Civik Thomas | director, officer: Interim CEO | Aug 12, 2026 | AWARD | 250,956 | $1.49 | $373.9K | Form 4 |
| GordonMD Global Investments LP | 10 percent owner | Jun 30, 2026 | OTHER | 0 | — | — | Form 4 |
| GordonMD Global Investments LP | 10 percent owner | Jun 30, 2026 | OTHER | 4,900,039 | $3.29 | $16.1M | Form 4 |
| Dupont Jakob | director | Jun 30, 2026 | OPTION EX. | 35,000 | $1.60 | $56.0K | Form 4 |
| Dupont Jakob | director | Jun 30, 2026 | OPTION EX. | 35,000 | $1.60 | $56.0K | Form 4 |
| Dupont Jakob | director | Jun 30, 2026 | SELL | 35,000 | $3.06 | $107.1K | Form 4 |
| Dupont Jakob | director | Mar 24, 2026 | AWARD | 45,867 | $1.36 | $62.4K | Form 4 |
| Wadhane Jitendra | Prin Fin & Acct Officer | Mar 24, 2026 | AWARD | 109,461 | — | — | Form 4 |
| Wadhane Jitendra | Prin Fin & Acct Officer | Mar 24, 2026 | AWARD | 262,635 | $1.36 | $357.2K | Form 4 |
| FLAVIN JOHN L | director | Mar 24, 2026 | AWARD | 45,867 | $1.36 | $62.4K | Form 4 |
| Metzger Michael A | director | Mar 24, 2026 | AWARD | 45,867 | $1.36 | $62.4K | Form 4 |
| Lewis-Hall Freda C | director | Mar 24, 2026 | AWARD | 45,867 | $1.36 | $62.4K | Form 4 |
| Cline Darren S | director | Mar 24, 2026 | AWARD | 45,867 | $1.36 | $62.4K | Form 4 |
| HUMPHREY RACHEL | director | Mar 24, 2026 | AWARD | 45,867 | $1.36 | $62.4K | Form 4 |
| Palani Santhosh | director | Mar 24, 2026 | AWARD | 45,867 | $1.36 | $62.4K | Form 4 |
| HUMPHREY RACHEL | director | Apr 14, 2025 | SELL | 1,400 | $0.97 | $1.4K | Form 4 |
| HUMPHREY RACHEL | director | Apr 17, 2025 | SELL | 200 | $0.97 | $194.00 | Form 4 |
| HUMPHREY RACHEL | director | Apr 21, 2025 | SELL | 13,896 | $1.03 | $14.4K | Form 4 |
| Civik Thomas | director, officer: Interim CEO | Feb 3, 2026 | AWARD | 690,131 | $1.49 | $1.0M | Form 4 |
| Sullivan Lara | director, officer: President ,CEO & CMO | Mar 31, 2025 | AWARD | 918,308 | $0.98 | $899.9K | Form 4 |
| Metzger Michael A | director | Mar 31, 2025 | AWARD | 36,979 | $0.98 | $36.2K | Form 4 |
| Wadhane Jitendra | SVP, Chief Accounting Officer | Mar 31, 2025 | AWARD | 263,782 | $0.98 | $258.5K | Form 4 |
| HUMPHREY RACHEL | director | Mar 31, 2025 | AWARD | 36,979 | $0.98 | $36.2K | Form 4 |
| Lewis-Hall Freda C | director | Mar 31, 2025 | AWARD | 36,979 | $0.98 | $36.2K | Form 4 |
| Cline Darren S | director | Mar 31, 2025 | AWARD | 36,979 | $0.98 | $36.2K | Form 4 |
| Dupont Jakob | director | Mar 31, 2025 | AWARD | 36,979 | $0.98 | $36.2K | Form 4 |
| Palani Santhosh | director | Mar 31, 2025 | AWARD | 36,979 | $0.98 | $36.2K | Form 4 |
| Civik Thomas | director | Mar 31, 2025 | AWARD | 36,979 | $0.98 | $36.2K | Form 4 |
| Connealy Pamela Ann | CFO & COO | Mar 31, 2025 | AWARD | 414,163 | $0.98 | $405.9K | Form 4 |
| FLAVIN JOHN L | director | Mar 31, 2025 | AWARD | 36,979 | $0.98 | $36.2K | Form 4 |
| Sullivan Lara | director, officer: Chief Executive Officer | Dec 23, 2024 | AWARD | 1,135,000 | $1.67 | $1.9M | Form 4 |
| Connealy Pamela Ann | CFO & COO | Dec 23, 2024 | AWARD | 310,000 | $1.67 | $517.7K | Form 4 |
| Wadhane Jitendra | SVP, Chief Accounting Officer | Dec 23, 2024 | AWARD | 150,000 | $1.67 | $250.5K | Form 4 |
| Connealy Pamela Ann | CFO & COO | Nov 26, 2024 | BUY | 83,400 | $1.96 | $163.5K | Form 4 |
| Connealy Pamela Ann | CFO & COO | Nov 26, 2024 | BUY | 5,450 | $2.00 | $10.9K | Form 4 |
| Metzger Michael A | director | Jun 10, 2024 | AWARD | 70,683 | $3.97 | $280.6K | Form 4 |
| Metzger Michael A | Jun 10, 2024 | OTHER | 0 | — | — | Form 4 | |
| Palani Santhosh | director | Jun 7, 2024 | AWARD | 6,000 | — | — | Form 4 |
| Connealy Pamela Ann | CFO & COO | Mar 26, 2024 | AWARD | 328,710 | — | — | Form 4 |
| Sullivan Lara | director, officer: Chief Executive Officer | Mar 26, 2024 | AWARD | 1,071,242 | $3.83 | $4.1M | Form 4 |
| FLAVIN JOHN L | director | Mar 26, 2024 | AWARD | 35,219 | — | — | Form 4 |
| Cline Darren S | director | Mar 26, 2024 | AWARD | 35,219 | — | — | Form 4 |
| Lewis-Hall Freda C | director | Mar 26, 2024 | AWARD | 35,219 | — | — | Form 4 |
| Dupont Jakob | director | Mar 26, 2024 | AWARD | 38,741 | — | — | Form 4 |
| HUMPHREY RACHEL | director | Mar 26, 2024 | AWARD | 38,741 | — | — | Form 4 |
| Civik Thomas | director | Mar 26, 2024 | AWARD | 44,024 | $3.83 | $168.6K | Form 4 |
| Wadhane Jitendra | SVP, Chief Accounting Officer | Mar 26, 2024 | AWARD | 131,484 | — | — | Form 4 |
| Palani Santhosh | director | Mar 12, 2024 | AWARD | 69,760 | $5.70 | $397.6K | Form 4 |
| Palani Santhosh | Mar 12, 2024 | OTHER | 0 | — | — | Form 4 | |
| Kobayashi Ken | Chief Medical Officer | Dec 29, 2023 | AWARD | 443,514 | $1.80 | $798.3K | Form 4 |
| Kobayashi Ken | Chief Medical Officer | Dec 29, 2023 | AWARD | 110,878 | $1.80 | $199.6K | Form 4 |
| Kobayashi Ken | officer | Nov 27, 2023 | OTHER | 0 | — | — | Form 4 |
| Connealy Pamela Ann | CFO and COO | Nov 29, 2023 | TAX W/H | 36,949 | $1.40 | $51.7K | Form 4 |
| Wadhane Jitendra | Chief Accounting Officer | Nov 15, 2023 | AWARD | 40,000 | — | — | Form 4 |
| Connealy Pamela Ann | CFO and COO | Sep 28, 2023 | BUY | 8,000 | $1.87 | $15.0K | Form 4 |
| Wadhane Jitendra | Chief Accounting Officer | Sep 27, 2023 | BUY | 2,500 | $1.87 | $4.7K | Form 4 |
| Connealy Pamela Ann | CFO and COO | Sep 27, 2023 | BUY | 6,426 | $1.85 | $11.9K | Form 4 |
| Dupont Jakob | director | Sep 22, 2023 | AWARD | 392,461 | $1.60 | $627.9K | Form 4 |
| Wadhane Jitendra | Chief Accounting Officer | Sep 25, 2023 | BUY | 5,000 | $1.77 | $8.8K | Form 4 |
| Connealy Pamela Ann | CFO and COO | Sep 25, 2023 | BUY | 12,000 | $1.67 | $20.0K | Form 4 |
| Wadhane Jitendra | Chief Accounting Officer | Sep 22, 2023 | BUY | 2,500 | $1.74 | $4.3K | Form 4 |
| Connealy Pamela Ann | CFO and COO | Sep 22, 2023 | BUY | 5,000 | $1.74 | $8.7K | Form 4 |
| Sullivan Lara | director, officer: President and CEO | Sep 14, 2023 | SELL | 100 | $2.25 | $225.00 | Form 4 |
| Sullivan Lara | director, officer: President and CEO | Sep 18, 2023 | SELL | 8,541 | $2.10 | $17.9K | Form 4 |
| Sullivan Lara | director, officer: President and CEO | Sep 11, 2023 | SELL | 20,000 | $2.27 | $45.4K | Form 4 |
| Sullivan Lara | director, officer: President and CEO | Sep 12, 2023 | SELL | 4,917 | $2.25 | $11.1K | Form 4 |
| Sullivan Lara | director, officer: President and CEO | Sep 13, 2023 | SELL | 3,000 | $2.27 | $6.8K | Form 4 |
| Sullivan Lara | director, officer: President and CEO | Sep 13, 2023 | TAX W/H | 184,742 | $2.13 | $393.5K | Form 4 |
| Connealy Pamela Ann | CFO and COO | Sep 7, 2023 | AWARD | 187,793 | — | — | Form 4 |
| Wadhane Jitendra | Chief Accounting Officer | Sep 7, 2023 | AWARD | 93,896 | — | — | Form 4 |
| Sullivan Lara | director, officer: President and CEO | Sep 7, 2023 | AWARD | 469,483 | — | — | Form 4 |
| Dupont Jakob | director | Aug 23, 2023 | AWARD | 17,250 | $15.37 | $265.1K | Form 4 |
| Dupont Jakob | director | Aug 23, 2023 | AWARD | 5,879 | $26.61 | $156.4K | Form 4 |
| Dupont Jakob | director | Aug 23, 2023 | AWARD | 3,534 | $26.61 | $94.0K | Form 4 |
| Dupont Jakob | director: | Aug 23, 2023 | OTHER | 0 | — | — | Form 4 |
| Sullivan Lara | director, officer: President and CEO | Mar 24, 2023 | AWARD | 703,379 | — | — | Form 4 |
| Sullivan Lara | director, officer: President and CEO | Mar 24, 2023 | AWARD | 990,461 | $2.21 | $2.2M | Form 4 |
| Sullivan Lara | director, officer: President and CEO | Mar 24, 2023 | AWARD | 61,825 | $2.21 | $136.6K | Form 4 |
| Sullivan Lara | director, officer: President and CEO | Mar 24, 2023 | DISPOSED | 61,825 | $8.71 | $538.5K | Form 4 |
| Sullivan Lara | director, officer: President and CEO | Mar 24, 2023 | DISPOSED | 990,461 | $5.34 | $5.3M | Form 4 |
| Yanchik Connealy Pamela | CFO and COO | Mar 24, 2023 | AWARD | 209,803 | — | — | Form 4 |
| Yanchik Connealy Pamela | CFO and COO | Mar 24, 2023 | AWARD | 322,265 | $2.21 | $712.2K | Form 4 |
| Yanchik Connealy Pamela | CFO and COO | Mar 24, 2023 | AWARD | 10,304 | $2.21 | $22.8K | Form 4 |
| Yanchik Connealy Pamela | CFO and COO | Mar 24, 2023 | DISPOSED | 10,304 | $8.71 | $89.7K | Form 4 |
| Feingold Jay | Chief Medical Officer | Mar 24, 2023 | AWARD | 209,803 | — | — | Form 4 |
| Feingold Jay | Chief Medical Officer | Mar 24, 2023 | AWARD | 157,257 | $2.21 | $347.5K | Form 4 |
| Feingold Jay | Chief Medical Officer | Mar 24, 2023 | AWARD | 17,517 | $2.21 | $38.7K | Form 4 |
| Feingold Jay | Chief Medical Officer | Mar 24, 2023 | DISPOSED | 17,517 | $8.71 | $152.6K | Form 4 |
| Wadhane Jitendra | Chief Accounting Officer | Mar 24, 2023 | AWARD | 157,257 | $2.21 | $347.5K | Form 4 |
| Wadhane Jitendra | Chief Accounting Officer | Mar 24, 2023 | AWARD | 29,393 | — | — | Form 4 |
| Wadhane Jitendra | Chief Accounting Officer | Mar 24, 2023 | AWARD | 45,000 | — | — | Form 4 |
| Wadhane Jitendra | Chief Accounting Officer | Mar 24, 2023 | DISPOSED | 157,257 | $8.71 | $1.4M | Form 4 |
| Lewis-Hall Freda C | director | Mar 24, 2023 | AWARD | 139,355 | — | — | Form 4 |
| HUMPHREY RACHEL | director | Mar 24, 2023 | AWARD | 58,064 | — | — | Form 4 |